Alkem Laboratories Limited
ALKEM
Pozycja w akcjach
#2887
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Cena akcji
$52.72
Kapitalizacja rynkowa
$6.30B
Zmiana (1 dzień)
-4.47%
Zmiana (1 rok)
-16.34%
Kraj
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategoria
Healthcare
Przychody dla Alkem Laboratories Limited (ALKEM)
Przychody w Jun 2026 TTM: $1.66B
Według najnowszych raportów finansowych Alkem Laboratories Limited, obecny przychód firmy (TTM) wynosi $1.66B. W roku 2025 firma osiągnęła przychód w wysokości $1.50B wzrost w porównaniu do przychodu z roku 2024, który wynosił $1.49B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Alkem Laboratories Limited od 2010 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $1.66B | 11.17% |
| 2025 | $1.50B | 0.36% |
| 2024 | $1.49B | 7.16% |
| 2023 | $1.39B | 0.53% |
| 2022 | $1.38B | 16.14% |
| 2021 | $1.19B | 9.65% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 8.08% |
| 2018 | $968.16M | 11.79% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 22.45% |
| 2013 | $419.09M | 10.73% |
| 2012 | $378.47M | 2.07% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 297.25% |
IN
|
